Takao Koichi, Sakatsume Tsukasa, Kamauchi Hitoshi, Sugita Yoshiaki
Laboratory of Bioorganic Chemistry, Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.
Chem Pharm Bull (Tokyo). 2020;68(11):1082-1089. doi: 10.1248/cpb.c20-00579.
A series of 2-(N-cyclicamino)chromone derivatives (1a-4c) and 3-(N-cyclicamino)chromone derivatives (5a-8c) were synthesized, and their monoamine oxidase (MAO) A and B inhibitory activities were studied as part of a structure-activity relationship investigation. Compounds 1a-4c showed no remarkable inhibition for MAO-A or MAO-B, whereas compounds 5a-8c (with a few exceptions) showed significant and selective inhibition of MAO-B. Of these compounds, 7c, 7-methoxy-3-(4-phenyl-1-piperazinyl)-4H-1-benzopyran-4-one inhibited MAO-B the most potently and selectively, having IC of 15 nM and an MAO-B selectivity index of more than 6700; c.f, 50 nM and 2000, respectively, for safinamide. The mode of inhibition of 7c to MAO-B was competitive and reversible. Considering the IC values and selectivity indices of the other synthetic compounds, the presence of the methoxy group on the chromone ring (R) of 7c seemed to increase MAO-B inhibition. Molecular docking analysis also supports this hypothesis. Our results suggest that 3-(N-cyclicamino)chromones are useful lead compounds for the development of MAO-B inhibitors.
合成了一系列2-(N-环氨基)色酮衍生物(1a - 4c)和3-(N-环氨基)色酮衍生物(5a - 8c),并作为构效关系研究的一部分,对它们的单胺氧化酶(MAO) A和B抑制活性进行了研究。化合物1a - 4c对MAO - A或MAO - B没有明显抑制作用,而化合物5a - 8c(少数例外)对MAO - B表现出显著的选择性抑制作用。在这些化合物中,7c,即7-甲氧基-3-(4-苯基-1-哌嗪基)-4H-1-苯并吡喃-4-酮对MAO - B的抑制作用最强且具有选择性,其IC50为15 nM,MAO - B选择性指数超过6700;相比之下,沙芬酰胺的IC50和选择性指数分别为50 nM和2000。7c对MAO - B的抑制模式是竞争性和可逆的。考虑到其他合成化合物的IC50值和选择性指数,7c色酮环(R)上甲氧基的存在似乎增强了对MAO - B的抑制作用。分子对接分析也支持这一假设。我们的结果表明,3-(N-环氨基)色酮是开发MAO - B抑制剂的有用先导化合物。